Newpath Partners, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for Prime Medicine, Inc. Common Stock, par value $0.00001 per share (PRME)

Filing Manager
Newpath Partners, L.P.
Reporting Manager
Newpath Partners, L.P.
Security
Prime Medicine, Inc. Common Stock, par value $0.00001 per share
Symbol
PRME
Shares outstanding
129,908,064 shares
Disclosed Ownership
6,105,679 shares
Ownership
4.7%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:15:10 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Newpath Partners, L.P. 4.7% 6,105,679 0 6,105,679 By: Newpath Partners GP, L.P. By: /s/ Thomas Cahill Thomas Cahill, Managing Member
Newpath Partners GP, L.P. 4.7% 6,105,679 0 6,105,679 By: Newpath Partners GP, LLC By: /s/ Thomas Cahill Thomas Cahill, Managing Member
Newpath Partners GP, LLC 4.7% 6,105,679 0 6,105,679 /s/ Thomas Cahill Thomas Cahill, Managing Member
Thomas Cahill 4.7% 6,105,679 0 6,105,679 /s/ Thomas Cahill Thomas Cahill